Montréal, December 14, 2020 – Génome Québec, in partnership with Genome Canada, is pleased to announce that two CARTaGENE scientific directors, Guillaume Lettre, PhD and Simon Gravel, PhD, have been awarded funding of more than $3 million for the GenoRef-Q Initiative. This initiative will sequence the genome of more than 2000 participants from previously genotyped individuals recruited for the CARTaGENE population-based cohort.
The funding comes from Genome Canada’s Regional Priorities Partnership Program (RP3), which aims to develop initiatives that advance genomics research and its practical translation capacity in areas of strategic priority specific to a given region. Génome Québec and Genome Canada contributed $2 million to the initiative, while CARTaGENE and the CHU Sainte-Justine each invested $100,000. This unprecedented achievement will also be made possible with significant support from the tech company Illumina.